All Stories

  1. Symptom and performance validation in patients with subjective cognitive decline and mild cognitive impairment
  2. Awareness of olfactory dysfunction in Parkinson’s disease.
  3. Semantic memory and depressive symptoms in patients with subjective cognitive decline, mild cognitive impairment, and Alzheimer's disease
  4. Assessment of individual cognitive changes after deep brain stimulation surgery in Parkinson’s disease using the Neuropsychological Test Battery Vienna short version
  5. The impact of depressive symptoms on health-related quality of life in patients with subjective cognitive decline, mild cognitive impairment, and Alzheimer's disease
  6. Self-reported and informant-reported memory functioning and awareness in patients with mild cognitive impairment and Alzheimer´s disease
  7. Subjective Memory Complaints and Conversion to Dementia in Patients with Subjective Cognitive Decline and Patients with Mild Cognitive Impairment
  8. Facial emotion recognition and its relationship to cognition and depressive symptoms in patients with Parkinson's disease
  9. Early dysfunctions of fronto-parietal praxis networks in Parkinson’s disease
  10. rs6295 [C]-Allele Protects against Depressive Mood in Elderly Endurance Athletes
  11. Activities of Daily Living and Depressive Symptoms in Patients with Subjective Cognitive Decline, Mild Cognitive Impairment, and Alzheimer’s Disease
  12. Facial emotion recognition in patients with subjective cognitive decline and mild cognitive impairment
  13. Health-Related Quality of Life in Patients with Subjective Cognitive Decline and Mild Cognitive Impairment and its Relation to Activities of Daily Living
  14. Gender-Specific Differences in Cognitive Profiles of Patients with Alzheimer’s Disease: Results of the Prospective Dementia Registry Austria (PRODEM-Austria)
  15. Depressive Symptoms are the Main Predictor for Subjective Sleep Quality in Patients with Mild Cognitive Impairment—A Controlled Study
  16. Physical Exercise Counteracts Genetic Susceptibility to Depression
  17. Visuo-constructional functions in patients with mild cognitive impairment, Alzheimer’s disease, and Parkinson’s disease
  18. Higher level of neuroticism in patients with problems with the sense of smell
  19. Finger dexterity deficits in Parkinson's disease and somatosensory cortical dysfunction
  20. Awareness of memory deficits in subjective cognitive decline, mild cognitive impairment, Alzheimer's disease and Parkinson's disease
  21. Subjective memory complaints, depressive symptoms and cognition in Parkinson's disease patients
  22. Prevalence of Mild Cognitive Impairment Subtypes in Patients with Parkinson’s Disease – Comparison of two Modes of Classification
  23. Subjective memory complaints, depressive symptoms and cognition in patients attending a memory outpatient clinic
  24. Subjective memory complaints, depressive symptoms and cognition in patients attending a memory outpatient clinic
  25. Impaired activation of somatosensory cortex as FMRI correlate of reduced dexterity in PD
  26. Gender specific differences in cognitive profiles of patients with Alzheimer dementia. Results of the prospective dementia registry Austria (PRODEM-Austria)
  27. Prevalence of mild cognitive impairment subtypes in patients attending a memory outpatient clinic—comparison of two modes of mild cognitive impairment classification. Results of the Vienna Conversion to Dementia Study
  28. The “Sense of Coherence” and the coping capacity of patients with Parkinson disease
  29. Development of a Brief Self-Report Inventory to Measure Olfactory Dysfunction and Quality of Life in Patients with Problems with the Sense of Smell
  30. Geschichte der Klinischen Psychologie am AKH Wien — Universitätskliniken
  31. Klinische Psychologie in der Neurologie
  32. Gedächtnisstörungen
  33. Demenzsyndrome
  34. Klinische Psychologie im Krankenhaus
  35. Klinische Neuropsychologie
  36. Cognitive function in elderly marathon runners: Cross-sectional data from the marathon trial (apsoem)
  37. FMRI correlates of apraxia in Parkinson's disease patients OFF medication
  38. Neurocognitive training in patients with high-grade glioma: a pilot study
  39. Odor Identification and Self-reported Olfactory Functioning in Patients with Subtypes of Mild Cognitive Impairment
  40. Probing ideomotor apraxia in Parkinson's Disease using fMRI
  41. Probing limb-kinetic apraxia in Parkinson's Disease using fMRI
  42. Der Verbale Selektive Reminding Test (VSRT): Ein Verfahren zur Überprüfung verbaler Gedächtnisfunktionen
  43. Improvement of neurocognitive function after protected carotid artery stenting
  44. Is There Improvement of “Vascular Depression” after Carotid Artery Stent Placement?
  45. Does modification of olfacto-gustatory stimulation diminish sensory-specific satiety in humans?
  46. Klinische Neuropsychologie
  47. Neuropsychological Outcome 6 Months after Unilateral Carotid Stenting
  48. Jährliche Konversionsrate von Patienten mit Gedächtnisbeeinträchtigung zur Alzheimerkrankheit: Der Einfluss von amnestischer MCI und die prädiktive Aussagekraft der neuropsychologischen Testung
  49. Ambient odors of orange and lavender reduce anxiety and improve mood in a dental office
  50. Depth of word processing in Alzheimer patients and normal controls: a magnetoencephalographic (MEG) study
  51. Preserved memory traces within diencephalic amnesia
  52. Olfaction and face encoding in humans: a magnetoencephalographic study
  53. Olfaction and Depth of Word Processing: A Magnetoencephalographic Study
  54. Evidence of conscious and subconscious olfactory information processing during word encoding: a magnetoencephalographic (MEG) study
  55. Neuropsychologie
  56. Ambient odor of orange in a dental office reduces anxiety and improves mood in female patients
  57. Die Wiener Olfaktorische Testbatterie (WOTB)
  58. Different forms of human odor memory: a developmental study
  59. Odor Identification, Consistency of Label Use, Olfactory Threshold and their Relationships to Odor Memory over the Human Lifespan
  60. Health-related quality of life (HRQOL), activity of daily living (ADL) and depressive mood disorder in temporal lobe epilepsy patients
  61. Event-related potentials in patients with temporal lobe epilepsy reveal topography specific lateralization in relation to the side of the epileptic focus
  62. Postictal nose wiping: A lateralizing sign in temporal lobe complex partial seizures
  63. Language-related hemispheric asymmetry in healthy subjects and patients with temporal lobe epilepsy as studied by event-related brain potentials and intracarotid amobarbital test
  64. Clinical seizure lateralization in mesial temporal lobe epilepsy: Differences between patients with unitemporal and bitemporal interictal spikes
  65. Olfactory Prodromal Symptoms and Unilateral Olfactory Dysfunction Are Associated in Patients with Right Mesial Temporal Lobe Epilepsy
  66. Olfactory Functions in Parkinson's Disease and Alzheimer's Disease
  67. Impaired olfactory function in Parkinson's disease
  68. Higher Olfactory Threshold and Decreased Odor Identification Ability in HIV-infected Persons
  69. Gender differences in long-term odor recognition memory: verbal versus sensory influences and the consistency of label use
  70. Demenzsyndrome
  71. Gedächtnisstörungen
  72. Development of Odor Naming and Odor Memory from Childhood to Young Adulthood